DK0533695T3 - Imidazo(4,5-c)pyridiner med PAF-antagonistaktivitet - Google Patents

Imidazo(4,5-c)pyridiner med PAF-antagonistaktivitet

Info

Publication number
DK0533695T3
DK0533695T3 DK91909431.8T DK91909431T DK0533695T3 DK 0533695 T3 DK0533695 T3 DK 0533695T3 DK 91909431 T DK91909431 T DK 91909431T DK 0533695 T3 DK0533695 T3 DK 0533695T3
Authority
DK
Denmark
Prior art keywords
pyridines
imidazo
antagonist activity
paf antagonist
paf
Prior art date
Application number
DK91909431.8T
Other languages
Danish (da)
English (en)
Inventor
Anthony Marfat
James Frederick Eggler
Kevin Cooper
Michael Jonathan Fray
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of DK0533695T3 publication Critical patent/DK0533695T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK91909431.8T 1990-05-09 1991-05-01 Imidazo(4,5-c)pyridiner med PAF-antagonistaktivitet DK0533695T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52119990A 1990-05-09 1990-05-09

Publications (1)

Publication Number Publication Date
DK0533695T3 true DK0533695T3 (da) 1995-01-09

Family

ID=24075786

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91909431.8T DK0533695T3 (da) 1990-05-09 1991-05-01 Imidazo(4,5-c)pyridiner med PAF-antagonistaktivitet

Country Status (28)

Country Link
EP (1) EP0533695B1 (de)
JP (1) JPH0678340B2 (de)
CN (1) CN1057839A (de)
AP (1) AP224A (de)
AT (1) ATE112567T1 (de)
AU (1) AU642265B2 (de)
BG (1) BG97059A (de)
BR (1) BR9106433A (de)
CA (1) CA2080476A1 (de)
DE (1) DE69104481T2 (de)
DK (1) DK0533695T3 (de)
ES (1) ES2061247T3 (de)
FI (1) FI925053A0 (de)
GT (1) GT199100031A (de)
HU (1) HUT62894A (de)
IE (1) IE911553A1 (de)
IL (1) IL98075A0 (de)
MA (1) MA22151A1 (de)
MY (1) MY105512A (de)
NO (1) NO924290L (de)
NZ (1) NZ238089A (de)
PE (1) PE26691A1 (de)
PT (1) PT97616A (de)
RO (1) RO109450B1 (de)
TW (1) TW205549B (de)
WO (1) WO1991017163A1 (de)
YU (1) YU81191A (de)
ZA (1) ZA913497B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9102997D0 (en) * 1991-02-13 1991-03-27 Pfizer Ltd Therapeutic agents
EP0656004A1 (de) * 1992-08-20 1995-06-07 Cytomed, Inc. Entzündungshemmende und immunsuppressive mittel mit zweifacher wirkungsweise
US6372770B1 (en) 1994-10-12 2002-04-16 Euro-Celtique, S.A. Benzoxazoles
ATE229015T1 (de) * 1998-05-12 2002-12-15 Wyeth Corp Zur behandlung von insulin-resistenz und hyperglycemie geeignete biphenyl-oxo-essigsäuren
US6232322B1 (en) 1998-05-12 2001-05-15 American Home Products Corporation Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
US6310081B1 (en) 1999-05-10 2001-10-30 American Home Products Corporation Biphenyl sulfonyl aryl carboxylic acids useful in the treatment of insulin resistance and hyperglycemia
GB0302094D0 (en) 2003-01-29 2003-02-26 Pharmagene Lab Ltd EP4 receptor antagonists
GB0324269D0 (en) 2003-10-16 2003-11-19 Pharmagene Lab Ltd EP4 receptor antagonists
CA2924168A1 (en) * 2013-09-13 2015-03-19 Cortendo Ab (Publ) Novel cytochrome p450 inhibitors and their method of use
CN105348182B (zh) * 2014-08-24 2018-04-13 复旦大学 2‑烷氧基苯甲酰芳胺类化合物及其药物用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES517193A0 (es) * 1981-11-10 1983-12-01 Wellcome Found Un procedimiento para la preparacion de nuevos derivados de imidazo (4,5-c)piridina.
GB8804439D0 (en) * 1988-02-25 1988-03-23 Pfizer Ltd Dihydropyridines
GB8822170D0 (en) * 1988-09-21 1988-10-26 Pfizer Ltd Therapeutic agents

Also Published As

Publication number Publication date
IE911553A1 (en) 1991-11-20
GT199100031A (es) 1992-10-30
NO924290D0 (no) 1992-11-06
TW205549B (de) 1993-05-11
PE26691A1 (es) 1991-10-21
DE69104481D1 (de) 1994-11-10
IL98075A0 (en) 1992-06-21
AU7867191A (en) 1991-11-27
PT97616A (pt) 1992-03-31
FI925053A (fi) 1992-11-06
CN1057839A (zh) 1992-01-15
ZA913497B (en) 1992-12-30
AP224A (en) 1992-10-27
FI925053A0 (fi) 1992-11-06
ATE112567T1 (de) 1994-10-15
WO1991017163A1 (en) 1991-11-14
CA2080476A1 (en) 1991-11-10
HUT62894A (en) 1993-06-28
MA22151A1 (fr) 1991-12-31
MY105512A (en) 1994-10-31
YU81191A (sh) 1994-06-10
AU642265B2 (en) 1993-10-14
EP0533695A1 (de) 1993-03-31
RO109450B1 (ro) 1995-02-28
DE69104481T2 (de) 1995-02-09
AP9100259A0 (en) 1991-07-31
HU9203496D0 (en) 1993-01-28
EP0533695B1 (de) 1994-10-05
JPH05505619A (ja) 1993-08-19
NO924290L (no) 1992-11-06
NZ238089A (en) 1992-10-28
ES2061247T3 (es) 1994-12-01
JPH0678340B2 (ja) 1994-10-05
BG97059A (bg) 1993-12-24
BR9106433A (pt) 1993-05-04

Similar Documents

Publication Publication Date Title
DE69011914D1 (de) Olefinisch substitierte 1H-Imidazo[4,5-c]chinolin-4-amine.
OA07130A (fr) Nouvelles imidazo[1,2-a]pyridines et pyridazines .
DK608887D0 (da) Imidazopyridinderivater
FI884312A0 (fi) Faestelement foersett med en underlaeggsbricka med stor yta.
DK532088A (da) Imidazopyridinforbindelser
DK495287D0 (da) 2-eller 3-arylsubstituerede imidazo(1,2-a)pyridi ner
DK151172C (da) Moebel, saasom sidde- eller liggemoebel
DE59009117D1 (de) [1,2,4] Triazolo [1,5-a]pyridine.
DK0533695T3 (da) Imidazo(4,5-c)pyridiner med PAF-antagonistaktivitet
ATE51232T1 (de) Tricyclische pyridonderivate.
FI903276A0 (fi) Cigarettstaenger med flytande flavoer i mitten.
NO882558D0 (no) Tricykliske pyridonderivater.
DK0483052T3 (da) Picolinoxider
EP0417760A3 (en) Phenylalkanoyl substituted imidazo(4,5-c) pyridines
IT8021821A0 (it) Pirido [1,2-a] pirimidine sostituite
NO923489D0 (no) 1,4-dihydroksypyridiner med paf-antagonistisk aktivitet
DK89287A (da) Siddemoebel
ATA26385A (de) Sitzmoebel
FI930108A (fi) Imidazopyridin-paf-antagonister
DK50586D0 (da) Siddemoebel
KR890010135U (ko) 슬라이딩 헹거
DK150699C (da) Udfoldeligt siddemoebel
DK144295A (da) Pyridinderivater med anti-ulcer aktivitet
MX9101899A (es) Indolizino(1,2-b)quinolinonas substituidas
SE8900639D0 (sv) Sittbadkar badkar